A cost-effectiveness model for coronary thrombolysis/reperfusion therapy
Abstract
A model was designed to examine the relations between incremental costs and benefits of coronary thrombolysis/reperfusion therapy. The model allows for the study of intravenous and intracoronary streptokinase, intravenous tissue plasminogen activator and primary angioplasty. Three strategies for the …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
models
Recurrence
risk factors
time factors
decision trees
theoretical*
cost-benefit analysis
pmid:2959718
doi:10.1016/s0735-1097(87)80432-1
g l laffel
h v fineberg
e braunwald
angioplasty
balloon / economics*
coronary angiography
coronary disease / economics*
coronary thrombosis / economics*
coronary thrombosis / mortality
coronary thrombosis / therapy
coronary vessels*
drug evaluation
myocardial infarction / economics
myocardial infarction / mortality
myocardial infarction / therapy
stroke volume / drug effects
Access
Citation
ID:
112421
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
112421
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet